New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareBPC-157 vs IGF-1 DES

BPC-157 vs IGF-1 DES

Side-by-side comparison of key properties, dosing, and research.

Recovery & Repair
BPC-157
Anabolic & IGF
IGF-1 DES
Summary
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in the stomach. It is one of the most extensively researched healing peptides, known for accelerating tissue repair, reducing inflammation, and protecting the gastrointestinal tract.
IGF-1 DES (also written DES(1-3)IGF-1) is a truncated form of IGF-1 missing the first three amino acids of the N-terminus. This structural change dramatically reduces its affinity for IGF binding proteins (IGFBPs), meaning a far greater fraction remains in its free, active form. IGF-1 DES is estimated to be 10x more potent than standard IGF-1 LR3 at the receptor level locally, making it particularly effective for site-specific muscle growth when injected intramuscularly.
Half-Life
4–6 hours
~20–30 minutes (very short — designed for local action)
Admin Route
SubQ, IM, Oral
IM, SubQ
Research
Typical Dose
200–500 mcg
20–50 mcg per injection site
Frequency
Once daily
Once daily, post-workout
Key Benefits
  • Accelerates wound healing and tissue repair
  • Reduces inflammation throughout the body
  • Protects and heals the gastrointestinal tract
  • Supports tendon and ligament healing
  • Promotes bone and joint health
  • May protect organs from toxins and injury
  • Supports gut-brain axis function
  • Counteracts NSAID-induced gut damage
  • Estimated 10x greater potency at the receptor vs IGF-1 LR3 locally
  • Minimal IGFBP binding — nearly all active upon injection
  • Highly localized muscle growth effect when injected intramuscularly
  • Activates satellite cells for muscle fiber hyperplasia potential
  • Synergistic with GH peptides in post-workout anabolic protocols
  • Shorter half-life reduces systemic exposure vs IGF-1 LR3
  • Useful for site-specific muscle development
Side Effects
  • Injection site discomfort
  • Nausea (rare)
  • Headache (rare)
  • Dizziness (rare)
  • Hypoglycemia (most significant risk — especially post-workout)
  • Localized muscle swelling at injection site
  • Potential for jaw/organ growth (acromegalic effects) with prolonged high-dose use
  • Carpal tunnel syndrome with high doses
  • +1 more
Stacks With